Literature DB >> 15163099

Frontal lobe seizures and uveitis associated with acute human parvovirus B19 infection.

David Hsu1, Christy Sandborg, Jin S Hahn.   

Abstract

We report a 5-year-old girl who developed repeated episodes of behavioral alterations shortly after human parvovirus B19 infection and uveitis. Video-electroencephalographic study demonstrated that these brief episodes were frontal lobe seizures. Seizures responded promptly to antiepilepsy medications. Further diagnostic testing did not reveal any rheumatologic disorders. Human parvovirus B19 infections in children are more commonly associated with febrile seizures and meningoencephalitis. Our case demonstrates that, rarely, it may be associated with the development of partial epilepsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15163099     DOI: 10.1177/088307380401900413

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  5 in total

1.  Detection of adeno-associated virus 2 and parvovirus B19 in the human dorsolateral prefrontal cortex.

Authors:  Jacqueline A Hobbs
Journal:  J Neurovirol       Date:  2006-06       Impact factor: 2.643

2.  Focal seizure associated with human parvovirus B19 infection in a non-encephalopathic child.

Authors:  Debopam Samanta; Erin Willis
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

Review 3.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

4.  Persistent adeno-associated virus 2 and parvovirus B19 sequences in post-mortem human cerebellum.

Authors:  James K Grant; Natalie C Yin; Annette M Zaytoun; Hena Waseem; Jacqueline A Hobbs
Journal:  Cerebellum       Date:  2009-07-08       Impact factor: 3.847

Review 5.  Neurological aspects of human parvovirus B19 infection: a systematic review.

Authors:  Faraj Barah; Sigrid Whiteside; Sonia Batista; Julie Morris
Journal:  Rev Med Virol       Date:  2014-01-24       Impact factor: 6.989

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.